What is Dr Reddy's Laboratories Price-to-Operating-Cash-Flow?
As of today (2024-12-15), Dr Reddy's Laboratories's share price is $14.46.
Dr Reddy's Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.49. Hence, Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow Ratio for today is 29.57.
The historical rank and industry rank for Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:
RDY'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.51 Med: 20.55 Max: 47.98
Current: 30.5
During the past 13 years, Dr Reddy's Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 47.98. The lowest was 9.51. And the median was 20.55.
Dr Reddy's Laboratories's Cash Flow from Operations per share for the
three
months ended in Sep. 2024 was $0.13.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.49.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Dr Reddy's Laboratories was -52.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 7.90% per year.
During the past 13 years, Dr Reddy's Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 75.20% per year. The lowest was -27.70% per year. And the median was 11.70% per year.
Dr Reddy's Laboratories Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Reddy's Laboratories Price-to-Operating-Cash-Flow Chart
|
Dr Reddy's Laboratories Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
17.35 |
21.04 |
25.48 |
13.06 |
22.59 |
|
Dr Reddy's Laboratories Quarterly Data
|
|
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
12.90 |
18.01 |
22.59 |
25.02 |
33.08 |
Competitive Comparison of Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow falls into.
Dr Reddy's Laboratories Price-to-Operating-Cash-Flow Calculation
Dr Reddy's Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 14.46 | / | 0.489 |
| = | 29.57 |
Dr Reddy's Laboratories's Share Price of today is $14.46.
Dr Reddy's Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Dr Reddy's Laboratories Business Description
Traded in Other Exchanges
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Dr Reddy's Laboratories Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RDY has been successfully added to your